SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently trending as investors debate its long-term viability, with a vocal segment of the community highlighting alternative meme tokens on other chains as more efficient options for supply burns and utility. Sentiment remains sharply divided between loyalists maintaining a long-term bullish outlook and skeptics who argue the token has lost its momentum and faces persistent downside pressure.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio Inc. (IBRX) is trending as retail investors engage in intense speculation regarding potential Russell 1000 index inclusion and upcoming clinical news, sparking a significant conflict between bullish sentiment and heavily positioned short sellers. The conversation is currently dominated by debate over the company's potential for a short squeeze and excitement surrounding its cancer immunotherapy pipeline.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple shares are facing significant downward pressure as investors weigh the potential for demand destruction following widespread price hikes across its hardware lineup, driven by rising costs in the semiconductor memory market. While some in the community view these increases as a strategic move to protect margins through Apple's strong ecosystem lock-in, others are bracing for volatility, closely watching key technical support levels to see if the pullback represents a major regime shift or a buying opportunity.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is capturing significant market attention following the successful FDA approval of its Thyroid Eye Disease treatment, Lumvoa. The community is actively discussing the potential for a rapid commercial rollout and the strategic advantage Lumvoa holds in both active and chronic patient populations, fueling speculation about long-term growth and potential acquisition interest.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergent Biosolutions is experiencing significant volatility as investors monitor a series of new strategic manufacturing contracts and pending financial results, while community sentiment remains divided between those betting on a turnaround under CEO Joe Papa and skeptics wary of dilution and debt levels. Conversations are heavily focused on the company's ability to secure government biodefense contracts, its efforts to stabilize balance sheets, and the potential impact of various infectious disease outbreaks on long-term demand.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is currently facing high volatility as investors weigh the company's aggressive revenue growth projections against concerns regarding ongoing insider selling and share dilution. The community is sharply divided, with some traders viewing the current pullback as a buying opportunity based on AI infrastructure demand, while others caution that the stock is fundamentally overvalued and prone to further downside.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is trending as retail investors aggressively trade the high-leverage ETF, fueled by intense demand for South Korean semiconductor giants like Samsung and SK Hynix that are critical to the AI memory supply chain. Community discussion centers on the extreme volatility and mechanics of this 3x leveraged product, with many debating whether the massive inflows into Korean tech represent a sustainable AI super-cycle or an overcrowded trade nearing a potential unwind.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is trending as investors rotate toward its unique tokenomics and high-speed perpetual exchange, which continues to see significant daily fee generation and automated token buybacks. Community members are actively debating the potential for long-term growth and its decoupling from traditional crypto assets, as the project gains traction for its ability to offer 24/7 leveraged access to real-world assets and pre-IPO equities.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is trending as investors debate whether recent volatility represents a buying opportunity or a deeper issue with commercial production scale, with community sentiment split between frustration over delayed milestones and long-term optimism regarding smart glasses and drone customer potential. Discussion is heavily focused on whether the company can successfully transition from development to high-volume manufacturing while navigating concerns about order flow and the competitive landscape of next-generation battery technology.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor Manufacturing is trending as investors weigh its dominant foundry position and advanced packaging role against persistent geopolitical risks and global supply constraints. The community is actively discussing TSMC's critical supply-chain bottleneck, its ability to maintain pricing power amid exploding AI demand, and how it compares to broader semiconductor sector leaders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Anworth Mortgage Asset Corporation (Anworth) is a real estate investment trust (REIT). The Company is engaged in the business of investing primarily in United States, or the United States agency mortgage-backed securities (agency MBS). The Companyâs operations consist of portfolios, including agency mortgage-backed securities (Agency MBS) and non-agency mortgage-backed securities (Non-Agency MBS). Approximately 99.99% of the Companyâs total portfolio consists of Agency MBS. At December 31, 2012, we held agency mortgage assets which had an amortized cost of approximately $9.02 billion, consisting primarily of approximately $7.07 billion of adjustable-rate Agency MBS and approximately $1.95 billion of fixed-rate Agency MBS. Non-Agency MBS were approximately $1.4 million for 2012. Non-Agency MBS portfolio consisted of a fair value of $360 thousand of floating-rate CMOs with an average coupon of 0.46%.

Anworth Mortgage Asset Corp.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

ANHAnworth Mortgage Asset Corporation

Latest ANH News